Horizon Pharma
Horizon Pharma Public Limited Company (NASDAQ: HZNP) is a specialty pharmaceutical company that develops and markets medicine through its subsidiaries in the United States. The company was founded in 2005 and is based in Dublin, Ireland. The company focuses on developing treatments for arthritis, pain and inflammatory diseases. Horizon's product portfolio includes Actimmune (interferon gamma), Duexis (ibuprofen + famotidine), Pennsaid (diclofenac, 2% topical), and Rayos/Lodotra (prednisone). In 2016, the company became a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Wikipage redirect
primaryTopic
Horizon Pharma
Horizon Pharma Public Limited Company (NASDAQ: HZNP) is a specialty pharmaceutical company that develops and markets medicine through its subsidiaries in the United States. The company was founded in 2005 and is based in Dublin, Ireland. The company focuses on developing treatments for arthritis, pain and inflammatory diseases. Horizon's product portfolio includes Actimmune (interferon gamma), Duexis (ibuprofen + famotidine), Pennsaid (diclofenac, 2% topical), and Rayos/Lodotra (prednisone). In 2016, the company became a member of the Pharmaceutical Research and Manufacturers of America (PhRMA).
has abstract
Horizon Pharma Public Limited ...... ufacturers of America (PhRMA).
@en
Horizon Pharma est une entrepr ...... inflammation et de l'arthrite.
@fr
founding year
key person
location
net income ($)
Link from a Wikipage to an external page
Wikipage page ID
42,291,505
Wikipage revision ID
739,070,377
industry
subject
hypernym
comment
Horizon Pharma Public Limited ...... ufacturers of America (PhRMA).
@en
Horizon Pharma est une entrepr ...... inflammation et de l'arthrite.
@fr
label
Horizon Pharma
@en
Horizon Pharma
@fr
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Horizon Pharma Plc
@en